WPC
UTHR icon

Wedmont Private Capital’s United Therapeutics UTHR Stock Holding History

Wedmont Private Capital’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$933K Hold
1,751
– – 0.02% 414
2026
Q2 		$958K Buy
1,751
+82
+5% +$46.2K 0.03% 361
2026
Q1 		$971K Hold
1,669
– – 0.03% 327
2025
Q4 		$841K Buy
1,669
+82
+5% +$38.2K 0.03% 332
2025
Q3 		$725K Buy
+1,587
New +$534K 0.03% 343
2025
Q1 		– Sell
-1,276
Closed -$466K – 767
2024
Q4 		$466K Buy
+1,276
New +$469K 0.02% 402

Other funds holding UTHR

AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
VFP
Vilga Financial Planning Fair Lawn, New Jersey $168M AUM 23.03% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
MNBTD
Moody National Bank Trust Division Galveston, Texas $1.21B AUM 28.25% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
BTC
Bank & Trust Company Litchfield, Illinois $159M AUM 30.15% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $766M AUM 16.04% 1-Year Est. Return
WWM
Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return
SRS
Strong Retirement Solutions Silverdale, Washington $178M AUM 20.42% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Wedmont Private Capital's UTHR Position: Q3 2026 in Review

Wedmont Private Capital held its United Therapeutics (UTHR) position steady in Q3 2026 at 1,751 shares worth $933K. The position accounts for 0.02% of the portfolio, ranked #414.

Wedmont Private Capital first reported a position in UTHR in Q4 2024 and has held it in 6 quarters since. The position peaked at $971K in Q1 2026. 21 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Wedmont Private Capital held 1,751 shares of United Therapeutics worth $933K as of Q3 2026.
  • Wedmont Private Capital left its United Therapeutics share count unchanged in Q3 2026.
  • United Therapeutics made up 0.02% of Wedmont Private Capital's portfolio in Q3 2026, its #414 holding.
  • Wedmont Private Capital first reported a position in United Therapeutics in Q4 2024 and has held it in 6 quarters since.
  • Wedmont Private Capital's United Therapeutics position peaked at $971K in Q1 2026.
  • 21 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Wedmont Private Capital's 13F filing for Q3 2026, filed 9 Oct 2026.